MEDICAMEN BI

Medicamen Biotech Ltd. engages in the manufacture and marketing of pharmaceutical formulations. The company is headquartered in New Delhi, Delhi. The firm is engaged in manufacturing pharmaceutical formulations products. The firm manufactures a range of products, including tablets, capsules, liquid syrup, dry syrup, such as beta-lactum and non-beta lactum, and ointments. The firm is primarily focused on oncology therapeutics. The firm is also focused on other therapeutic areas, such as cardiology, central nervous system (CNS), diabetology and pain management. The firm's oncology products include Abiraterone acetate, Anastrozole, Bicalutamide, Bendmustine HCL, Bortezomib, Busulfan, Capecitabine, Cisplatin, Erlotinib HCL, Gefitinib, Imatinib mesylate, Lenalidomide, Letrozole, Melphalan, Nilotinib HCI, Oxaliplatin, Pazopanib, Pomalidomide and Tegafur. The firm has two manufacturing plants at Bhiwadi (Rajasthan) and Haridwar (Uttarakhand). The firm's wholly owned subsidiary is OPAL Pharmaceuticals Pty Ltd.